AVAI BIO, INC. Net Income (Loss) Available to Common Stockholders, Basic
AVAI BIO, INC. (AVAI) reported Net Income (Loss) Available to Common Stockholders, Basic of -$552.04 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-13
- AVAI BIO, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$552.04K.
- AVAI BIO, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$255.18K.
- AVAI BIO, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$553.73K, a 222.43% decline year-over-year.
- AVAI BIO, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$453.02K, a 172.71% decline year-over-year.
- AVAI BIO, INC. net income (loss) available to common stockholders, basic for fiscal 2026 was -$1.75M.
- AVAI BIO, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$1.14M.
- AVAI BIO, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$126.52K.
- AVAI BIO, INC. net income (loss) available to common stockholders, basic for fiscal 2021 was -$302.29K.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$552.04K 10-Q · filed 2026-08-13 | -$807.22K derived: sum of 2 quarters · filed 2026-08-13 | -$1.36M derived: sum of 3 quarters · filed 2026-08-13 | -$1.81M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$255.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$808.90K derived: sum of 2 quarters · filed 2026-07-14 | -$1.26M derived: sum of 3 quarters · filed 2026-07-14 | -$1.75M 10-K · filed 2026-07-14 |
| 2025-12-31 | -$553.73K 10-Q · filed 2026-02-12 | -$1.01M derived: sum of 2 quarters · filed 2026-02-12 | -$1.49M 10-Q · filed 2026-02-12 | -$4.24M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | -$453.02K 10-Q · filed 2025-11-14 | -$940.61K 10-Q · filed 2025-11-14 | -$3.69M derived: sum of 3 quarters · filed 2026-08-13 | -$3.24M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$487.59K 10-Q · filed 2026-08-13 | -$3.24M derived: sum of 2 quarters · filed 2026-08-13 | -$2.78M derived: sum of 3 quarters · filed 2026-08-13 | -$2.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$2.30M derived: sum of 2 quarters · filed 2026-07-14 | -$1.67M derived: sum of 3 quarters · filed 2026-07-14 | -$1.14M 10-K · filed 2026-07-14 |
| 2024-12-31 | $452.30K 10-Q · filed 2026-02-12 | $1.08M derived: sum of 2 quarters · filed 2026-02-12 | $1.61M 10-Q · filed 2026-02-12 | |
| 2024-09-30 | $623.05K 10-Q · filed 2025-11-14 | $1.15M 10-Q · filed 2025-11-14 | ||
| 2022-06-30 | -$29.76K 10-Q · filed 2022-08-19 | |||
| 2022-03-31 | -$126.52K 10-K · filed 2022-06-29 | |||
| 2021-12-31 | -$349.33K 10-Q · filed 2022-02-14 | |||
| 2021-06-30 | $396.33K 10-Q · filed 2022-08-19 | |||
| 2021-03-31 | -$302.29K 10-K · filed 2022-06-29 | |||
| 2020-06-30 | $48.68K 10-Q · filed 2022-02-14 |